Brief: Galera Reports Fourth Quarter And Full Year 2021 Financial Results And Recent Corporate Updates

Obsidian Therapeutics

10/03/2022 12:41

March 10 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL
RESULTS AND RECENT CORPORATE UPDATES
    * Q4 LOSS PER SHARE $0.64
    * DATA READOUTS FROM AESOP IN ESOPHAGITIS AND GRECO-1 IN
LUNG
CANCER EXPECTED IN 1H 2022
    * STRONG CASH POSITION OF $71M WITH EXPECTED CASH RUNWAY
INTO 2H
2023

Source text for Eikon:  ID:nGNX5RlWyt 
Further company coverage:  GRTX.O